Direxion Daily S&P Biotech Bear 3X ETF
LABD
9 hedge funds and large institutions have $3.98M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
348% more call options, than puts
Call options by funds: $4.93M | Put options by funds: $1.1M
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
175% more capital invested
Capital invested by funds: $1.45M → $3.98M (+$2.53M)
50% more funds holding
Funds holding: 6 → 9 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$2.62M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$468K |
| 3 |
Jane Street
New York
|
+$468K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$468K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$281K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$93.5K |
| 2 |
Morgan Stanley
New York
|
-$93.5K |
LABD Hedge Fund Activity: Q3 2016 in Review
9 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2016, worth a combined $3.98M — up 175% from $1.45M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LABD positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $2.62M. The largest seller was Flow Traders U.S., exiting entirely with an estimated $93.5K sold.
- 9 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2016, up from 6 in Q2 2016.
- Funds reported $3.98M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2016, up 175% quarter-over-quarter.
- 4 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2016 and 1 closed out, a net change of +3 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2016 was Virtu Financial, an estimated $2.62M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2016 was Flow Traders U.S., an estimated $93.5K sold.
Based on aggregated 13F filings for Q3 2016.